Protalix BioTherapeutics
PLX
#8929
Rank
C$0.23 B
Marketcap
C$2.87
Share price
4.06%
Change (1 day)
34.27%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): C$0.02393

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is C$0.02796. In 2024 the company made an earnings per share (EPS) of C$0.05593 a decrease over its 2023 EPS that were of C$0.17.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$0.02393-57.22%
2024C$0.05593-66.67%
2023C$0.17-138.71%
2022C-$0.43-50%
2021C-$0.87181.82%
2020C-$0.31-82.11%
2019C-$1.72-31.67%
2018C-$2.52-72.31%
2017C-$9.09124.14%
2016C-$4.05-147.54%
2015C$8.53-290.63%
2014C-$4.476.67%
2013C-$4.19130.77%
2012C-$1.82-69.77%
2011C-$6.0119.44%
2010C-$5.03-12.2%
2009C-$5.7336.67%
2008C-$4.19-37.5%
2007C-$6.7150%
2006C-$4.473.23%
2005C-$4.33138.46%
2004C-$1.82-74%
2003C-$6.99-0%
2002C-$6.99-50%
2001C-$13.98233.33%
2000C-$4.19-84.21%
1999C-$26.56-24%
1998C-$34.95-600%
1997C$6.99-16.67%
1996C$8.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.83 6,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$9.38 33,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.15-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.92 6,750.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel